Auxilium Pharmaceuticals Inc.
Description Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, together with its subsidiaries, develops and markets pharmaceutical products worldwide. It markets Testim, a topical 1% testosterone once-a-day gel for the treatment of hypogonadism; and XIAFLEX, an injectable clostridial collagenase enzyme for the treatment of Dupuytrens in adult patients with a palpable cord. The company is also developing XIAFLEX, which is in Phase III clinical trial for the treatment of Peyronies disease; and in Phase II clinical trial for the treatment of Adhesive Capsulitis, as well as in Phase II clinical trial for the treatment of edematous fibrosclerotic panniculopathy. In addition, it is developing a high concentration testosterone gel product. Further, the company has rights to pursue additional indications for collagenase clostridium histolyticum. Auxilium Pharmaceuticals, Inc. sells its products to wholesale drug distributors, specialty pharmacies, specialty distributors, and chain drug stores. The company was founded in 1999 and is headquartered in Chesterbrook, Pennsylvania. To view the detailed information, you need to SUBSCRIBE with us. |
 |